Information card for entry 1549006
Chemical name |
(4<i>Z</i>)-1-Benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one |
Formula |
C19 H18 N2 O2 |
Calculated formula |
C19 H18 N2 O2 |
SMILES |
O=C1N(c2c(NC(=C\C(=O)C)/C1)cccc2)Cc1ccccc1 |
Title of publication |
A monoclinic modification of (4<i>Z</i>)-1-benzyl-4-(2-oxopropylidene)-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one |
Authors of publication |
Samba, Mohamed; Minnih, Mohamed Said; El Bakri, Youness; Essassi, El Mokhtar; Mague, Joel T. |
Journal of publication |
IUCrData |
Year of publication |
2018 |
Journal volume |
3 |
Journal issue |
2 |
Pages of publication |
x180326 |
a |
8.9229 ± 0.0005 Å |
b |
18.8922 ± 0.001 Å |
c |
9.7147 ± 0.0005 Å |
α |
90° |
β |
104.879 ± 0.001° |
γ |
90° |
Cell volume |
1582.73 ± 0.15 Å3 |
Cell temperature |
100 ± 2 K |
Ambient diffraction temperature |
100 ± 2 K |
Number of distinct elements |
4 |
Space group number |
14 |
Hermann-Mauguin space group symbol |
P 1 21/n 1 |
Hall space group symbol |
-P 2yn |
Residual factor for all reflections |
0.0476 |
Residual factor for significantly intense reflections |
0.043 |
Weighted residual factors for significantly intense reflections |
0.115 |
Weighted residual factors for all reflections included in the refinement |
0.1196 |
Goodness-of-fit parameter for all reflections included in the refinement |
1.029 |
Diffraction radiation wavelength |
0.71073 Å |
Diffraction radiation type |
MoKα |
Has coordinates |
Yes |
Has disorder |
No |
Has Fobs |
Yes |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/1549006.html